Canada markets closed

Petros Pharmaceuticals, Inc. (PTPI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.6200-0.2200 (-7.75%)
At close: 04:00PM EST
2.6200 0.00 (0.00%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close2.8400
Open2.7100
Bid2.6000 x 1200
Ask2.6200 x 800
Day's Range2.5300 - 2.8000
52 Week Range1.1900 - 5.2000
Volume1,156,394
Avg. Volume18,399,726
Market Cap54.063M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.6170
Earnings DateMay 17, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021

    LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience.The SNN Network Summer Virtual Event begins on Tuesday, August 17, 2021 with the "MicroCap Investing Workshop" starting at 8:00am EST and featuring well-known financial influencers, investors, fund managers, and key opinion leaders, incl

  • Newsfile

    Petros Pharmaceuticals: Invitation to the Q3 Virtual Investor Summit

    New Jersey and Pennsylvania--(Newsfile Corp. - August 11, 2021) - Petros Pharmaceuticals (NASDAQ: PTPI) today announced that Fady Boctor, President, Chief Commercial Officer will be attending the Q3 Virtual Investor Summit. Event Q3 Investor Summit Date August 17-18th, 2021 Presentation August 17th at 12:30 PM ET Location https://zoom.us/webinar/register/WN_snUNAVzVTH2geFZUKGFMEQ About Petros PharmaceuticalsPetros Pharmaceuticals aims to be a premier Men’s health therapeutics company, prescripti

  • GlobeNewswire

    Petros Pharmaceuticals to Participate in NobleCon17

    NEW YORK, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals (Nasdaq: PTPI) today announces that its president and chief commercial officer Fady Boctor will present at NobleCon17 - Noble Capital Markets’ Seventeenth Annual Investor Conference on Wednesday, January 20, 2021 at 9:00 AM ET in Track 2. A high-definition, video webcast of the presentation will be available the following day on the Company's website www.petrospharma.com, and as part of a complete catalog of presentations to be rebroadcast on Channelchek (www.channelchek.com) next month. The conference is virtual, with no cost, obligation or restrictions to attend. Interested investors should visit www.noblecon17.com for more information. About Petros PharmaceuticalsPetros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders. About Noble Capital Markets, Inc.Noble Capital Markets (“Noble”) is a research driven boutique investment bank that has supported small & microcap companies since 1984. As a FINRA and SEC licensed and registered broker-dealer Noble provides institutional-quality equity research, merchant and investment banking, wealth management and order execution services. In 2005, Noble established NobleCon, an investor conference that has grown substantially over the last decade+. In 2018 Noble launched www.channelchek.com, an investment community dedicated exclusively to small and micro-cap companies and their industries. Channelchek is tailored to meet the needs of self-directed investors and financial professionals and is the first service to offer institutional-quality research to the public, for FREE at every level without a subscription. More than 6,000 emerging growth companies are listed on the site, with growing content including webcasts, industry sector reports, advanced market data and balanced news. CONTACTS:Jules AbrahamCORE IR917-885-7378pr@coreir.com